Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial

BACKGROUND: Duchenne muscular dystrophy (DMD) is an inherited neuromuscular disorder of childhood with a devastating disease course. Several targeted gene therapies and molecular approaches have been or are currently being tested in clinical trials; however, a causative therapy is still not availabl...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Trials
Hlavní autoři: Nagy, Sara, Hafner, Patricia, Schmidt, Simone, Rubino-Nacht, Daniela, Schädelin, Sabine, Bieri, Oliver, Fischer, Dirk
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6869203/
https://ncbi.nlm.nih.gov/pubmed/31752977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3740-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky